Crinetics (CRNX): Volume dana dhuwit perusahaan

CRNX (Crinetics Pharmaceuticals, Inc.) - tandha merek perusahaan

The implementation of AI modeling and robotic peptide screening drives the price action of the GURU.Markets cash balance chart, where the metric value stands at 1.20. Liquidity supports the monopolist status of Crinetics Pharmaceuticals (CRNX) in the rare endocrine pathology niche, shielding the company from the expansion of behemoths capable of leveraging colossal budgets to push smaller players out of this scientific race.

Sisa dhuwit perusahaan: Crinetics Pharmaceuticals, Inc. (CRNX) kanggo 04.07.2022 - 12.09.2026

Crinetics (CRNX) - rincian metrik lan laporan keuangan

- nilai saham lan prakiraan konsensus rega:
Analisis kabeh metrik perusahaan:Crinetics Pharma CRNX
Produk mawa merek crinetics.com

To objectively evaluate an issuer, a manager must understand the balance between liquidity and capital efficiency. By analyzing the cash balance, an investor determines the company's ability to withstand macroeconomic shocks without compromising asset returns. For Crinetics Pharmaceuticals (CRNX), such reserves are critical when developing innovative oral medications, ensuring financial stability during the diversification of its drug portfolio for rare endocrine pathologies.

Pesaing wigati

Dana dhuwit perusahaan ascendispharma.com (ASND)|Dhuwit awis perusahaan madrigalpharma.com MDGL|Volume dana dhuwit perusahaan CORT (Corcept Therapeutics Inc.)|Sisa dhuwit perusahaan RYTM|AKRO - Dana dhuwit perusahaan|Cadangan dhuwit perusahaan Metsera Inc|MoonLake Immunotherapeutics AG (MLTX) - Dana dhuwit perusahaan|Dhuwit awis perusahaan NewAmsterdam Pharma|SLNO (Soleno Therapeutics Corp) - Volume dana dhuwit perusahaan|Dhuwit awis perusahaan Amicus Pharma (FOLD)|Dhuwit awis perusahaan ETNB (89bio Corp)|Aset likuid perusahaan Agios Pharmaceuticals|Structure Pharma - Dhuwit awis perusahaan|MDXG: Dhuwit awis lan setara dhuwit awis perusahaan|RZLT: Dhuwit awis perusahaan|LXRX (Lexicon Pharma) - Dhuwit awis lan setara dhuwit awis perusahaan|MBX: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Altimmune, Inc. (ALT)|Dhuwit awis perusahaan AARD|Dana dhuwit perusahaan SGMT|Volume dana dhuwit perusahaan BIOA|Aset likuid perusahaan Biomea Fusion|Dana dhuwit perusahaan Quince Therapeutics QNCX|Volume dana dhuwit perusahaan Fractyl Health, Inc GUTS|VTVT: Dhuwit awis perusahaan|Cadangan dhuwit perusahaan Agape ATP|PLUR (Pluri) - Dhuwit awis perusahaan|SYBX - Aset likuid perusahaan|Dana dhuwit perusahaan Lipocine Corp|Volume dana dhuwit perusahaan matinasbiopharma.com|Dana dhuwit perusahaan Spruce Biosciences, Inc. (SPRB)|Gunggung dana dhuwit perusahaan GLTO|Carmell Corporation - Dhuwit awis perusahaan|LUMO - Dhuwit awis perusahaan|ONVO - Dana dhuwit perusahaan|Sisa dhuwit perusahaan RDUS (Radius Health)